These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9133883)

  • 21. Treatment of hepatitis C infection. Review underplayed important public health issues.
    Agarwal K; Jones DD
    BMJ; 1999 Aug; 319(7207):450-1. PubMed ID: 10445936
    [No Abstract]   [Full Text] [Related]  

  • 22. [Changes of serum 2',5'-oligoadenylate synthetase activity and neopterin during interferon treatment for chronic hepatitis C].
    Daito K; Suou T; Kawasaki H
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):981-5. PubMed ID: 7563914
    [No Abstract]   [Full Text] [Related]  

  • 23. [Fluctuation of hepatitis C virus quasispecies with interferon treatment and interferon-resistant variants in hepatitis C virus 1b].
    Sakuma I; Enomoto N; Asahina Y; Kurosaki M; Sato C
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):930-5. PubMed ID: 7563904
    [No Abstract]   [Full Text] [Related]  

  • 24. [Liver histology as a predictor of the response to interferon therapy].
    Okuno T; Arai K; Shindo M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):975-80. PubMed ID: 7563913
    [No Abstract]   [Full Text] [Related]  

  • 25. Maximizing the benefits of antiviral therapy for HCV: the advantages of treating side effects.
    Gish RG
    Gastroenterol Clin North Am; 2004 Mar; 33(1 Suppl):xxiii-xxiv. PubMed ID: 15081104
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatitis C. New treatment helps some, but cure remains elusive.
    Henkel J
    FDA Consum; 1999; 33(2):23-9. PubMed ID: 10214120
    [No Abstract]   [Full Text] [Related]  

  • 27. [Change of HCV-RNA levels in liver tissue and interferon responsiveness in patients with chronic hepatitis C].
    Takeuchi M; Kaneko S; Unoura M; Kobayashi K
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):969-74. PubMed ID: 7563912
    [No Abstract]   [Full Text] [Related]  

  • 28. Interferon for hepatitis C: where it has been and where it is going.
    Koretz RL
    Immunotherapy; 2013 Jul; 5(7):673-5. PubMed ID: 23829615
    [No Abstract]   [Full Text] [Related]  

  • 29. Antiviral agents in the treatment of chronic viral hepatitis.
    Perrillo RP
    Prog Liver Dis; 1992; 10():283-309. PubMed ID: 1284255
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hepatitis C today].
    Bourlière M
    Soins; 1999 Dec; (641):33-6. PubMed ID: 10857435
    [No Abstract]   [Full Text] [Related]  

  • 31. Interferon therapy in hepatitis C virus (HCV) induced chronic hepatitis: clinical significance of pretreatment with glycyrhizine.
    Fujisawa K
    Trop Gastroenterol; 1991; 12(4):176-9. PubMed ID: 1726032
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of post-transfusion hepatitis.
    Hoofnagle JH; Di Bisceglie AM; Lisker-Melman M; Kassianides C; Martin P
    Transfus Med Rev; 1988 Dec; 2(4):215-20. PubMed ID: 2485159
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of type C fulminant and subfulminant hepatitis--featuring antiviral and immunosuppressive treatment].
    Yoshiba M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):549-56. PubMed ID: 7563822
    [No Abstract]   [Full Text] [Related]  

  • 34. [Interferon therapy for acute hepatitis C: evaluation by HCV antibody, HCV genotypes and serum RNA titer].
    Toyama H; Iwabuchi S
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):521-7. PubMed ID: 7563813
    [No Abstract]   [Full Text] [Related]  

  • 35. Consensus among consensus conferences on management of hepatitis C: what we knew then and are still sure about, what we are newly sure about, and what we still need to know.
    Farrell GC
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E126-9. PubMed ID: 10921395
    [No Abstract]   [Full Text] [Related]  

  • 36. Timing of IFN therapy initiation for acute hepatitis C after accidental needlestick.
    Sata M; Ide T; Noguchi S; Hashimoto O; Kumashiro R; Suzuki H; Tanikawa K
    J Hepatol; 1997 Aug; 27(2):425-6. PubMed ID: 9288621
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prediction of interferon therapy outcome by PCR-SSCP analysis of HCV 5' NCR].
    Kurihara C; Katayama K; Fukushi S; Hoshino FB; Ando T; Oya A; Ishiyama N
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):326-32. PubMed ID: 7563742
    [No Abstract]   [Full Text] [Related]  

  • 38. Future therapies for hepatitis C.
    Pawlotsky JM; Gish RG
    Antivir Ther; 2006; 11(4):397-408. PubMed ID: 16856613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Post-transfusion hepatitis C, its diagnosis and treatment].
    Takano S; Omata M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):510-4. PubMed ID: 7563809
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical evaluation of positive- and negative-stranded HCV-RNAs in liver in relation to IFN therapy].
    Hino K; Murakami C; Fujii K; Okazaki M; Okuda M; Hanada H; Okita K
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):949-53. PubMed ID: 7563907
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.